Wanted Dead or Alive: A Correlate of Protection Against Dengue Virus

Wanted Dead or Alive: A Correlate of Protection Against Dengue Virus

Bibliographic Details
Main Authors:	Lázaro Gil, Alejandro Martín, Laura Lazo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-12-01
Series:	Frontiers in Immunology
Subjects:	dengue virus vaccines antibodies cell-mediate immunity protection antibody-dependent enhancement of infection
Online Access:	https://www.frontiersin.org/article/10.3389/fimmu.2019.02946/full

Similar Items

Addition of Partial Envelope Domain II into Envelope Domain III of Dengue Virus Antigen Potentiates the Induction of Virus-Neutralizing Antibodies and Induces Protective Immunity
by: Jisang Park, et al.
Published: (2020-02-01)

The dengue vaccine challenges
by: Radka KOMITOV, et al.
Published: (2022-03-01)

The Human Antibody Response to Dengue Virus Infection
by: Aravinda M. de Silva, et al.
Published: (2011-11-01)

Call to Action for Dengue Vaccine Failure
by: Suresh Mahalingam, et al.
Published: (2013-08-01)

Japanese Encephalitis DNA Vaccines with Epitope Modification Reduce the Induction of Cross-Reactive Antibodies against Dengue Virus and Antibody-Dependent Enhancement of Dengue Virus Infection
by: Tomohiro Kotaki, et al.
Published: (2022-08-01)

Cross-Protection of Dengue Virus Infection against Congenital Zika Syndrome, Northeastern Brazil
by: Celia Pedroso, et al.
Published: (2019-08-01)

A Model of Vaccination for Dengue in the Philippines 2016–2018
by: Pierre Magal, et al.
Published: (2021-10-01)

Dengue virus neutralizing antibody: a review of targets, cross-reactivity, and antibody-dependent enhancement
by: Animesh Sarker, et al.
Published: (2023-06-01)

Manipulation of immunodominant dengue virus E protein epitopes reduces potential antibody-dependent enhancement
by: Hughes Holly R, et al.
Published: (2012-06-01)

Cross-reactive dengue virus-derived monoclonal antibodies to Zika virus envelope protein: Panacea or Pandora’s box?
by: Shannon A. Gunawardana, et al.
Published: (2018-12-01)

Sculpting humoral immunity through dengue vaccination to enhance protective immunity
by: Wayne eCrill, et al.
Published: (2012-11-01)

Dengue 2 virus enhancement in asthmatic and non asthmatic individual
by: Maria G. Guzman, et al.
Published: (1992-12-01)

The Ability of Zika virus Intravenous Immunoglobulin to Protect From or Enhance Zika Virus Disease
by: Amelia K. Pinto, et al.
Published: (2021-09-01)

Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine
by: Rahul Shukla, et al.
Published: (2020-10-01)

Plasmid DNA encoding neutralizing human monoclonal antibody without enhancing activity protects against dengue virus infection in mice
by: Surachet Benjathummarak, et al.
Published: (2021-01-01)

Safety and immunogenicity of a single dose, live-attenuated ‘tetravalent dengue vaccine’ in healthy Indian adults; a randomized, double-blind, placebo controlled phase I/II trial
by: Lalitendu Mohanty, et al.
Published: (2022-04-01)

Pichia pastoris-expressed Dengue 3 Envelope-based Virus-like Particles Elicit Predominantly Domain III-Focused High Titer Neutralizing Antibodies
by: Lav eTripathi, et al.
Published: (2015-09-01)

Mouse models to study dengue virus immunology and pathogenesis
by: Raphaël M. Zellweger, et al.
Published: (2014-04-01)

Anti-Idiotypic Antibodies Specific to prM Monoantibody Prevent Antibody Dependent Enhancement of Dengue Virus Infection
by: Miao Wang, et al.
Published: (2017-05-01)

Safety issues from a Phase 3 clinical trial of a live-attenuated chimeric yellow fever tetravalent dengue vaccine
by: Scott B. Halstead
Published: (2018-09-01)

Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design?
by: Lucas Wilken, et al.
Published: (2020-06-01)

Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology
by: Lalita Priyamvada, et al.
Published: (2017-01-01)

Severity and Outcomes of Dengue in Hospitalized Jamaican Children in 2018–2019 During an Epidemic Surge in the Americas
by: Aileen May Lue, et al.
Published: (2022-06-01)

T-cell Responses in Individuals Infected with Zika Virus and in Those Vaccinated Against Dengue Virus
by: Dominic Paquin-Proulx, et al.
Published: (2017-06-01)

The Mathematical Modeling of the Host–Virus Interaction in Dengue Virus Infection: A Quantitative Study
by: Zhaobin Xu, et al.
Published: (2024-01-01)

Dendritic cells in dengue virus infection: Targets of virus replication and mediators of immunity
by: Michael A. Schmid, et al.
Published: (2014-12-01)

Improved Immune Responses Against Zika Virus After Sequential Dengue and Zika Virus Infection in Humans
by: Félix G. Delgado, et al.
Published: (2018-09-01)

Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis
by: Yi-Ling Cheng, et al.
Published: (2022-08-01)

Antibody-Dependent Enhancement and Zika: Real Threat or Phantom Menace?
by: Miguel A. Martín-Acebes, et al.
Published: (2018-02-01)

Role of pre-existing immunity in driving the dengue virus serotype 2 genotype shift in the Philippines: A retrospective analysis of serological data
by: Jean Claude Balingit, et al.
Published: (2024-02-01)

Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice
by: Lucas Wilken, et al.
Published: (2023-03-01)

Landscape of Monoclonal Antibodies Targeting Zika and Dengue: Therapeutic Solutions and Critical Insights for Vaccine Development
by: Vincent Dussupt, et al.
Published: (2021-02-01)

Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?
by: Iris Valdés, et al.
Published: (2019-08-01)

Comparative Analysis of In Vitro Models to Study Antibody-Dependent Enhancement of Zika Virus Infection
by: Thomas Langerak, et al.
Published: (2022-12-01)

Biological view of vaccination described by mathematical modellings: from rubella to dengue vaccines
by: Hyun Mo Yang, et al.
Published: (2019-04-01)

Modeling Dengue Immune Responses Mediated by Antibodies: A Qualitative Study
by: Afrina Andriani Sebayang, et al.
Published: (2021-09-01)

Antibodies Elicited by an NS1-Based Vaccine Protect Mice against Zika Virus
by: Mark J. Bailey, et al.
Published: (2019-04-01)

Dysfunctional Innate Immune Responses and Severe Dengue
by: Gathsaurie Neelika Malavige, et al.
Published: (2020-10-01)

Comodulation of Dengue and Chikungunya Virus Infection During a Coinfection Scenario in Human Cell Lines
by: Debjani Taraphdar, et al.
Published: (2022-04-01)

Efficacy of a live attenuated highly pathogenic PRRSV vaccine against a NADC30-like strain challenge: implications for ADE of PRRSV
by: Xin-xin Chen, et al.
Published: (2021-07-01)